Region may have world’s highest rate, investigators say.
Glaucoma 360: Highlights from 2021
Investigators from various companies described their diagnostic offerings at the Glaucoma Research Foundation’s 2021 New Horizons Forum.
Telemedicine provides readiness in time of crisis.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: Peter Kaiser explains the ongoing SOL-1 and SOL-R study of OTX-TKI
2
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa
3
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial
4
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA
5
.png "Optometry Times"){kind=logo}
